"","Num","POD","SD","%","Genes","KE"
"CTOME FATTY ACYL COA BIOSYNTHESIS","2","0.00214341593438623","1.39322268280451","40","fasn, hacd3","UP REGULATION ACETYL-COA CARBOXYLASE-1 ACC-1"
"GO:0015464","2","0.00250380748994786","1.38424258525499","25","chrm2a, chrna6","ACTIVATION NICOTINIC ACETYLCHOLINE RECEPTOR"
"INHIBITION ACETYLCHOLINESTERASE ACHE","2","0.00250380748994786","1.38424258525499","18.18","chrm2a, chrna6","INHIBITION ACETYLCHOLINESTERASE ACHE"
"LIPID METABOLISM PATHWAY","3","0.0360213396615085","0.96397193318576","25","bckdha, fasn, prkaa1","DAMAGE LIPID BILAYER"
"CTOME CELLULAR RESPONSE TO HYPOXIA","5","0.0378654041947103","0.361424851224703","11.63","hif1ab, psma1, psmb3, psmb4, psmd9","N/A HYPOXIA"
"GO:1903009","5","0.0488071676998553","0.376489271412099","14.71","psma1, psmb3, psmb4, psmc1a, psmd9","DECREASE GTPCH-1"
"GO:0019882","8","0.099449660381885","0.186320683708543","13.56","canx, CD68, psma1, psmb3, psmb4, psmc1a, psmd9, sec13","GENERATION OF NOVEL EPITOPES  ANTIGEN PRESENTATION"
"GO:0006633","7","0.150350755105104","0.254642849290177","24.14","fasn, hacd3, lias, lpgat1, lpl, prkaa1, ptgesl","SYNTHESIS DE NOVO FA; INCREASED DE NOVO FA SYNTHESIS; INCREASED DE NOVO FA SYNTHESIS"
"GO:0036475","2","0.168393946980803","0.0988484610899654","40","ctnnb1, hif1ab","N/A NEURONAL DYSFUNCTION"
"GO:0003158","7","0.168457653429812","0.261540247854785","29.17","acvr1l, acvr2b, csnk2b, ctnnb1, f11r.1, fasn, hoxb5a","IMPAIRMENT ENDOTHELIAL NETWORK"
"VENTRICULAR ARRHYTHMIA","2","0.186354804408728","0.0340086009369852","28.57","bmp2a, raf1b","OCCURRENCE CARDIAC ARRHYTHMIA"
"GO:0008152","2","0.188873425979869","0.0195939703365967","66.67","naga, pfkpa","PRODUCTION CRITICAL METABOLITES CGA 330050 AND CGA 265307; METABOLISM OF AFB1 PRODUCTION OF REACTIVE ELECTROPHILES"
"GO:0007268","9","0.21851149486964","0.183410632517429","25.71","cacna1ba, cacna1bb, chrm2a, chrna6, gabra1, gabra5, glrba, htr2cl1, htr3a","REDUCTION NEURONAL SYNAPTIC INHIBITION"
"SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR","3","0.231978799956318","0.0654649645847392","8.82","mapk3, ptena, raf1b","OCCURRENCE CYTOPLASMIC VACUOLIZATION HEPATOCYTE; OCCURRENCE BALLOONING DEGENERATION HEPATOCYTE"
"GO:0042541","2","0.238427953122539","0.00794636677149728","40","hif1ab, inhbab","FORMATION FORMATION OF HEMOGLOBIN ADDUCTS"
"GO:0006816","2","0.245591326518723","0.0316085584479016","18.18","cacna1ba, cacna1bb","DECREASED CALCIUM INFLUX; REDUCTION CA AND HCO3 TRANSPORT TO SHELL GLAND; OPENING OF CALCIUM CHANNEL CALCIUM INFLUX"
"GO:0015908","4","0.260286880755929","0.0652194035985596","18.18","cpt2, drd2b, ncor1, syk","INCREASED FA INFLUX"
"GO:0007612","4","0.262304762334805","0.0135519897621226","16.67","drd2b, gabra5, hif1ab, vdac1","IMPAIRMENT LEARNING AND MEMORY"
"GO:0030331","3","0.262919135951547","0.0972248922201618","33.33","ctnnb1, pcna, taf10","INCREASED ER BINDING TO DNA CLASSICAL PATHWAY; INCREASED ER BINDING TO TF TO DNA NON-CLASSICAL PATHWAY"
"GO:0007249","7","0.274587373925281","0.0395425963136729","16.28","ctnnb1, golt1bb, hacd3, hdac1, nfkb1, nfkb2, ppm1bb","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"PEPTIDYL LYSINE MODIFICATION","13","0.27864301463957","0.0928697969919547","18.31","ctnnb1, egr1, hat1, hdac1, lias, mapk3, nos1, nup93, pax5, prkaa1, sirt3, sumo2b, taf10","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"CTOME IKBA VARIANT LEADS TO EDA ID","2","0.279623886047219","0.0155124474016993","50","nfkb1, nfkb2","INDUCTION IKB INHIBITORY PROTEIN"
"GO:0003714","5","0.282217824028042","0.0635222139889317","25","e2f8, hdac1, ncor1, sap18, tfap2b","STABILIZATION PPAR ALPHA CO-REPRESSOR"
"GO:0005125","3","0.286546239822906","0.0609906138306811","12","bmp2a, gpia, inhbab","ACTIVATION INFLAMMATORY CYTOKINES CHEMOKINES CYTOPROTECTIVE GENE PATHWAYS"
"GLOMERULAR SCLEROSIS","3","0.292717544384652","0.123286749740297","21.43","ikbkap, nup93, sdhc","DECREASED GLOMERULAR FILTRATION"
"REGULATION OF PH","5","0.297933184932979","0.0267651790041978","35.71","atp6ap1b, atp6v1c1a, atp6v1e1b, atp6v1f, mapk3","DECREASE INTRACELLULAR PH"
"LYMPHOCYTE APOPTOTIC PROCESS","2","0.300418650558451","0.0789184768089889","25","hif1ab, ptena","DECREASED LYMPHOCYTES"
"GO:0010468","3","0.320036327873122","0.064670338432101","18.75","gata5, mapk3, mapk9","DECREASED TRANSCRIPTION OF GENES BY AR"
"CTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP","4","0.327824494608568","0.692661769662593","33.33","dhcr7, fasn, hmgcs1, lss","UP REGULATION SREBF2"
"HEMOGLOBIN METABOLIC PROCESS","4","0.337620438947919","0.051736040263136","66.67","alas1, cat, hif1ab, inhbab","ALTERED REGULATION ALPHA HEMOGLOBIN"
"GO:0005254","3","0.364906416148216","0.296087457546044","33.33","gabra1, gabra5, glrba","ACTIVATION GLUTAMATE-GATED CHLORIDE CHANNEL; ACTIVATION GLUTAMATE-GATED CHLORIDE CHANNELS"
"GO:1902476","3","0.364906416148216","0.296087457546044","50","gabra1, gabra5, glrba","INCREASED CHLORIDE CONDUCTANCE"
"REGULATION OF WNT SIGNALING PATHWAY","17","0.388867553147482","0.0744841239915551","21.52","bambia, bmp2a, csnk1e, csnk1g2a, ctnnb1, egr1, gli1, gsk3ab, hdac1, nfkb1, ppp2r1b, psma1, psmb3, psmb4, psmd9, stk11, ubr5","INHIBITION WNT PATHWAY"
"INCREASED LEVEL OF HIPPURIC ACID IN URINE","2","0.39935446786423","0.201985580525246","66.67","bckdha, hmgcl","INCREASED BLOOD URIC ACID CONCENTRATION"
"CTOME SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R","4","0.401907399509203","0.354274474108925","30.77","fgf8a, fgfr4, igf1ra, nras","INCREASED IGF-1 MOUSE"
"ABNORMAL PLEURA MORPHOLOGY","2","0.402414833387023","0.202400804239981","25","bmp2a, ikbkap","PERSISTENT CYTOTOXICITY PLEURA OR PERITONEUM"
"MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION","2","0.404416563361495","0.0465754805699148","20","fbxo5, rps3","DEPOLYMERIZATION MICROTUBULE"
"G TGF BETA SIGNALING PATHWAY","9","0.407546286859394","0.0677750681148388","13.24","acvr1l, acvr2b, bmp2a, fsta, inhbab, mapk3, ppp2r1b, tfdp1a, tgfbr2","ACTIVATION TGF-BETA PATHWAY; UP REGULATION TGFBETA1 EXPRESSION"
"G GLUTATHIONE METABOLISM","2","0.412016068756015","0.184896717579485","25","gstk1, pgd","DEPLETION GSH"
"GO:0006954","21","0.418003332867743","0.0556657160756387","17.95","acvr1l, adora2aa, bmp2a, CD68, ctsc, f11r.1, f3a, f3b, hif1ab, lias, lpl, nfkb1, nfkb2, nppa, ogg1, prkcz, psma1, psmb4, scn1lab, syk, vcam1","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"GO:0006936","11","0.433025862004583","0.139923695047219","20","calm1b, chrm2a, drd2b, mylpfa, neurog1, nos1, nppa, pgam2, scn1lab, tnnc2, tnnt2a","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"ABNORMAL LIVER MORPHOLOGY","24","0.437021211786288","0.045786995369173","20.17","acat1, agla, atp6ap1b, bmp2a, cpox, cpt2, ctnnb1, ctsc, dhdds, dnajb11, hmgcl, hmgcs1, hnf1ba, lpl, naga, ndufs4, nras, psmb4, ptena, raf1b, rras, tars, tkta, tnnt2a","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"ABNORMALITY OF THE PITUITARY GLAND","8","0.438908546217327","0.124043460820807","16.67","ar, ctnnb1, fgf8a, nfkb2, otx2, polr3h, rbm28, tgfbr2","INCREASED ADENOMAS PITUITARY"
"GO:0001816","18","0.456140827929907","0.0382480989171012","15","ctnnb1, cyp1b1, drd2b, egr1, f11r.1, hif1ab, hsf1, inhbab, lpl, mapk3, nfkb1, nfkb2, polr3h, ppm1bb, prkcz, rps3, syk, uba1","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"STEROID HORMONE MEDIATED SIGNALING PATHWAY","9","0.456217036436359","0.0779661468380454","8.82","ar, esrrga, hdac1, ncoa4, ncor1, nr3c2, paqr7b, rxrba, ubr5","DECREASE STEROIDOGENIC ACUTE REGULATORY PROTEIN STAR; DECREASED HSD17B10 EXPRESSION; REDUCED MATURATION INDUCING STEROID PLASMA"
"GO:0005216","10","0.45855788880287","0.0596045567511145","41.67","cacna1ba, cacna1bb, chrna6, gabra1, gabra5, glrba, gria2b, grik1b, htr3a, scn1lab","IMPAIRED ION CHANNELS"
"GO:0007269","10","0.463342962914461","0.163939342115354","40","adora2aa, cacna1ba, chrm2a, chrna6, drd2b, lin7a, P2RY1, pfn2l, rab5ab, slc32a1","OVERACTIVATION NEURONOTRANSMITTER RELEASE"
"ENDOMETRIAL CANCER","8","0.466666057611388","0.0786330952823759","11.76","casp9, ctnnb1, foxo3b, mapk3, nras, ptena, raf1b, tcf7","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"CTOME METABOLISM OF PORPHYRINS","2","0.467593035311674","0.089280867387041","66.67","alas1, cpox","ACCUMULATION HIGHLY CARBOXYLATED PORPHYRINS"
"PROLONGED NEONATAL JAUNDICE","2","0.470915086827897","0.0871068177754557","33.33","atp6ap1b, cpox","PROLONGED ESTRUS"
"IMMUNOLOGIC HYPERSENSITIVITY","4","0.482610775920425","0.0486359848859423","17.39","fgf8a, grhl2b, nfkb2, tbx1","INCREASE ALLERGIC RESPIRATORY HYPERSENSITIVITY RESPONSE"
"SANDAL GAP","2","0.483763141773894","0.258940210587914","40","bmp2a, igf1ra","N/A GAP"
"GO:0030545","6","0.487199109780669","0.100126506721082","10.17","bmp2a, fgf8a, fsta, gpia, inhbab, nppa","DESENSITIZATION NICOTINIC ACETYLCHOLINE RECEPTOR"
"GO:0001516","2","0.504432950799085","0.2528992900393","50","ptgesl, ptgs2a","REDUCED PROSTAGLANDIN F2ALPHA SYNTHESIS OVARY; DECREASED PROSTAGLANDIN F2ALPHA SYNTHESIS OVARY"
"GLUTATHIONE METABOLIC PROCESS","2","0.509265060341749","0.249971561708838","20","gstk1, ptgesl","GLUTATHIONE SYNTHESIS; GLUTATHIONE HOMEOSTASIS"
"ABNORMALITY OF THE MITOCHONDRION","6","0.519664682098763","0.112857015498105","4.76","cpt2, echs1, fdxr, hmgcl, ndufs4, sucla2","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"JNK CASCADE","6","0.52307232144957","0.107191152147354","27.27","hacd3, igf1ra, mapk9, ncor1, nppa, syk","ACTIVATION JNK"
"DECREASED FERTILITY","6","0.534675639689711","0.191552107762109","7.89","ar, ercc3, fgf8a, otx2, polr3h, raf1b","IMPAIRED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; REDUCTION CUMULATIVE FECUNDITY AND SPAWNING; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY; DECREASED TESTOSTERONE"
"BREAST CANCER PATHWAY","12","0.538073814885937","0.0425925990634014","10.53","cdk6, csnk2b, ctnnb1, fgf8a, fzd2, igf1ra, mapk3, nfkb2, nras, ptena, raf1b, tcf7","N/A BREAST CANCER"
"GO:0050663","5","0.539347926756544","0.106472984815872","16.67","drd2b, lpl, mapk3, prkcz, syk","RELEASE CYTOKINE"
"ABNORMALITY OF ADRENAL PHYSIOLOGY","4","0.553283970937981","0.212493421710927","4.35","ctnnb1, nfkb2, nr3c2, rbm28","INCREASE RENAL PATHOLOGY DUE TO VTG DEPOSITION; DECREASED RENAL ABILITY TO DILUTE URINE; OCCURRENCE KIDNEY TOXICITY; INCREASED KIDNEY FAILURE"
"OXIDATIVE DAMAGE","4","0.554352536084687","0.0713169159298544","20","casp3b, casp9, nfkb1, pcna","INCREASED OXIDATIVE DAMAGE"
"FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION","3","0.557613022293423","0.138774222894416","11.54","casp3b, casp9, pak2a","ACTIVATION FAS; UP REGULATION FAS"
"RESPONSE TO ESTRADIOL","9","0.558988133634309","0.0537771994932724","30","arpc1b, casp3b, cat, ccna2, ctnnb1, hsf1, ogg1, pcna, ptena","REDUCTION PLASMA 17BETA-ESTRADIOL CONCENTRATIONS"
"ABNORMAL CIRCULATING FATTY ACID CONCENTRATION","2","0.57112292721914","0.0921216593656022","22.22","cpt2, hmgcl","ACCUMULATION FATTY ACID"
"DECREASED PLASMA CARNITINE","2","0.57112292721914","0.0921216593656022","28.57","cpt2, hmgcl","REDUCTION PLASMA VITELLOGENIN CONCENTRATIONS; INCREASE PLASMA VITELLOGENIN CONCENTRATIONS; DECREASED RENAL PLASMA FLOW; INCREASED PLASMA TYROSINE; DECREASED PROSTAGLANDIN F2ALPHA CONCENTRATION PLASMA"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","31","0.580122412604888","0.0357484879008958","21.09","atp6v1e1b, bmp2a, cacna1ba, cat, ccnf, cdc45, ctsc, dhcr7, ercc3, fgf8a, gli1, ikbkap, nfkb1, nfkb2, nos1, nras, otx2, polr3h, psat1, psmb4, ptena, raf1b, rps15a, rras, scn1lab, stk11, tars, tbx1, tgfbr2, tnnt2a, uba1","INCREASED RESPIRATORY DISTRESS/ARREST"
"GO:0004970","2","0.583603336643913","0.0382596032164803","33.33","gria2b, grik1b","BINDING OF AGONIST IONOTROPIC GLUTAMATE RECEPTORS"
"ABNORMALITY OF THE ABDOMINAL ORGANS","37","0.583874255526634","0.0265448942254871","21.89","acat1, acvr2b, agla, atp6ap1b, bckdha, bmp2a, cpox, cpt2, ctnnb1, ctsc, dhcr7, dhdds, dnajb11, gpia, hmgcl, hmgcs1, hnf1ba, ikbkap, lpl, naga, ndufs4, nfkb1, nfkb2, nras, pdx1, psmb4, ptena, raf1b, rras, sdhc, sec23b, stk11, tars, tbx1, tgfbr2, tkta, tnnt2a","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"ABNORMALITY OF THE LIVER","34","0.584704808520096","0.0300359019516609","4.53","acat1, agla, atp6ap1b, bmp2a, cpox, cpt2, ctnnb1, ctsc, dhcr7, dhdds, dnajb11, gpia, hmgcl, hmgcs1, hnf1ba, lpl, naga, ndufs4, nfkb1, nfkb2, nras, pdx1, psmb4, ptena, raf1b, rras, sdhc, sec23b, stk11, tars, tbx1, tgfbr2, tkta, tnnt2a","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"GO:0010463","4","0.590127608490134","0.213207217262835","33.33","bmp2a, ctnnb1, tbx1, tgfbr2","INCREASED PROLIFERATION OF MESENCHYMAL CELLS"
"ABNORMAL RENAL TUBULE MORPHOLOGY","2","0.596401301586506","0.10542162212132","22.22","cpt2, ndufb8","OCCURRENCE CYSTIC DILATATION RENAL TUBULE; OCCURRENCE CYTOPLASMIC VACUOLIZATION RENAL TUBULE"
"REGULATION OF ATPASE ACTIVITY","5","0.598227727166371","0.136337301785525","31.25","dnajb11, hspa5, pfn2l, ssbp1, tnnt2a","INHIBITION CA++ ATPASE"
"GO:0042698","6","0.621478457521884","0.0977906645620766","27.27","casp2, casp3b, egr1, hspa5, inhbab, pcna","IRREGULARITIES OVARIAN CYCLE"
"DECREASED BODY WEIGHT","41","0.623490834233319","0.0239388194129739","18.14","acat1, acvr1l, arpc1b, atp6v1e1b, cacna1ba, cars, cdc45, dhcr7, dhdds, echs1, ercc3, fdxr, fgf8a, gabra5, gli1, hmgcl, igf1ra, mccc2, ndufb8, ndufs4, nfkb1, nfkb2, nos1, nr3c2, pdx1, psat1, psmb4, ptena, rpl18, rpl35a, rps15a, scn1lab, sdhc, sec23b, ssr4, strada, sucla2, tbx1, tgfbr2, uba1, znf711","DECREASED BODY WEIGHT"
"GO:0042446","7","0.623877651108754","0.104843680082702","25","bmp2a, dhcr7, egr1, fdx1, fdxr, hif1ab, nfkb1","INCREASE LUTEINIZING HORMONE LH; REPRESSED EXPRESSION OF STEROIDOGENIC ENZYMES"
"HEPATOCELLULAR CARCINOMA","4","0.629938176885617","0.212700235594025","30.77","bmp2a, cpox, ctnnb1, tgfbr2","FORMATION HEPATOCELLULAR AND BILE DUCT TUMORS; INCREASE ADENOMAS/CARCINOMAS HEPATOCELLULAR; TUMORIGENESIS HEPATOCELLULAR CARCINOMA"
"GO:0046983","44","0.635115464508881","0.0209691125970115","22.34","acat1, acvr1l, adora2aa, ahr1b, aldh1a3, ar, arntl2, aurka, bmp2a, cars, cat, cdh10a, cpox, drd2b, e2f8, eno3, f11r.1, fasn, gabbr2, h2afx, hif1ab, hmgcl, hmgcs1, hnf1ba, hsf1, hsp90aa1.2, inhbab, lpl, naga, neurog1, nfkb1, nfs1, P2RY1, pdx1, ppp2r1b, raf1b, ran, rpl7, tars, tbx1, tfap2b, tfdp1a, tkta, ttk","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"PYRUVATE METABOLIC PROCESS","13","0.645389398709593","0.0542925284002373","23.21","eno3, gpia, hif1ab, ncor1, nup93, ogdhb, pgam1a, pgam1b, pgam2, pkma, prkaa1, sec13, vdac1","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"GO:0030163","25","0.648674222567869","0.0458505552050376","16.34","anapc10, aurka, ccnb1, ccnf, cdk1, csnk1e, ctnnb1, ctsc, fbxo5, gsk3ab, hsp90aa1.2, hspa5, mapk9, plk1, prp19, psma1, psmb3, psmb4, psmc1a, psmd9, ptena, sumo2b, uba1, ube2kb, usp14","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"GO:0005515","14","0.653962851519716","0.0679602563639557","29.79","acvr1l, arntl2, ctnnb1, fgfr4, foxo3b, gata5, gli1, hsp90aa1.2, igfbp7, neurog1, ran, ta, tbx1, thraa","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"POSITIVE REGULATION OF GENE EXPRESSION","37","0.664752007013662","0.0220533229375436","20.44","ar, bmp2a, ctnnb1, cyp1b1, ddx39b, egr1, eif4g2b, f3a, fgf8a, fgfr4, gata5, gpia, gsk3ab, hdac1, hif1ab, hmx2, hsp90aa1.2, inhbab, lpcat3, lpl, mapk3, mapk9, ncor1, nfkb1, nfkb2, nos1, pkma, polr3h, prkaa1, prkcz, prp19, ptena, rps3, rps4x, syk, tra2b, ubr5","ALTERED GENE EXPRESSION"
"GO:0005102","34","0.665737302573694","0.016990701182721","16.35","adora2aa, ar, bambia, bmp2a, canx, casp3b, cat, ccnb1, csnk2b, ctnnb1, drd2b, eif3s10, f11r.1, fgf8a, fsta, gabra5, gnat2, gpia, gsk3ab, hif1ab, igf1ra, inhbab, lpl, ncoa4, ncor1, nppa, P2RY1, pcna, ptena, ran, syk, taf10, tgfbr2, vcam1","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","21","0.666180011174582","0.0413283111931154","20.39","ahr1b, ar, bmp2a, ctnnb1, dhdds, eif2b2, ercc3, fgf8a, hnf1ba, idh3a, lss, nras, otx2, polr3h, psat1, raf1b, rbm28, rho, rps4x, rras, tkta","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"GO:0009790","41","0.6668332871919","0.0212779742836586","24.26","acvr1l, acvr2b, aldh1a3, ar, bmp2a, casp3b, ccnb1, cdk1, cpt2, ctnnb1, e2f8, ercc3, fgf8a, fzd2, gli1, grhl2b, hdac1, hif1ab, hmx2, hnf1ba, hoxb2a, hoxb5a, hoxb8a, hsf1, inhbab, lias, mapk3, mmp2, neurog1, otx2, pax5, pdx1, prp19, rdh10a, rpl38, rrp7a, sf3b6, tbx1, tcf7, tgfbr2, tra2b","DEFECT OF EMBRYOGENESIS"
"GO:0007568","28","0.66946335886112","0.0345793175811044","32.56","canx, casp2, casp9, cat, CD68, cdk1, cdk6, ctsc, ddc, eno3, fbxo5, gsk3ab, h2afx, mapk3, nfkb2, ogg1, P2RY1, pax5, pdx1, pitx3, ptena, rpn2, SERP1, sirt3, slc32a1, sod2, tgfbr2, vcam1","ACCELERATED AGING"
"PARALYSIS","4","0.675276852301229","0.179072164445746","17.39","ccnf, cpox, scn1lab, sdhc","INDUCTION SOMATIC MUSCLE PARALYSIS; INDUCTION PHARYNGEAL MUSCLE PARALYSIS"
"GO:0004882","6","0.687293746045596","0.15115039159009","17.14","ar, cdk1, ctnnb1, hdac1, ncoa4, ran","N/A ANDROGEN RECEPTOR ANTAGONISM; AGONISM ANDROGEN RECEPTOR; DECREASED ANDROGEN RECEPTOR ACTIVITY; ACTIVATION ANDROGEN RECEPTOR"
"ABNORMAL LUNG MORPHOLOGY","27","0.690500202748606","0.0278025897097058","21.09","atp6v1e1b, bmp2a, cacna1ba, cdc45, ctsc, dhcr7, ercc3, fgf8a, gli1, ikbkap, nfkb1, nfkb2, nos1, nras, polr3h, psat1, ptena, raf1b, rps15a, rras, scn1lab, stk11, tars, tbx1, tgfbr2, tnnt2a, uba1","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"HEART DEVELOPMENT","25","0.692495348554807","0.0238690257694059","19.84","acvr1l, bmp2a, casp3b, ccnb1, ctnnb1, ddx39b, dhrs3a, eif4g2b, fgf8a, fzd2, gata5, gli1, grhl2b, gsk3ab, hif1ab, mapk3, nos1, nppa, pcna, ptena, raf1b, tbx1, tgfbr2, tnnt2a, vcam1","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"HYPERACTIVITY","13","0.706746177037302","0.042797000928871","26","cacna1ba, cars, dhcr7, dhdds, fgf8a, gabra1, gabra5, ppp2r1b, scn1lab, tbx1, tgfbr2, tkta, znf711","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","42","0.724101900738721","0.0238033256270859","10.4","acat1, acvr1l, alg6, arpc1b, atp6ap1b, atp6v1e1b, cat, cpox, cpt2, ctnnb1, cyp26c1, echs1, ercc3, gli1, gpia, hmgcl, mtap, ndufb8, ndufs4, nfkb1, nfkb2, nos1, nras, pdx1, psmb4, ptena, raf1b, rpl18, rpl35a, rps15a, rras, scn1lab, sdhc, sec23b, ssr4, stk11, tars, tbx1, tgfbr2, thraa, tnnt2a, uba1","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"REGULATION OF CELL DEATH","59","0.724662069603099","0.0113001194846208","22.01","acvr1l, adora2aa, aldh1a3, ar, aurka, bbc3, bmp2a, casp2, casp3b, casp9, cat, cdk1, ciapin1, creb3l3l, ctnnb1, ctsc, cyp1b1, egr1, ercc3, fgf8a, foxo3b, gabra5, gsk3ab, hdac1, hif1ab, hnrpkl, hsf1, hsp90aa1.2, hspa5, igf1ra, inhbab, mapk9, nfkb1, nme2b.2, nos1, ogg1, pa2g4b, pak2a, pdx1, pitx3, plk1, ppp2r1b, prkaa1, prkcz, ptena, raf1b, rps3, sap18, sgk1, sod2, syk, tbx1, tfap2b, tfap2d, thraa, txn, vdac1, ywhaqa, ywhaqb","N/A CELL INJURY/DEATH"
"HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY","4","0.732226598575122","0.196696669983084","3.7","egr1, igf1ra, mapk3, raf1b","DECREASED TRIIODOTHYRONINE T3 IN SERUM; INCREASE THYROID-STIMULATING HORMONE TSH; DECREASED THYROXINE T4 IN SERUM; INCREASED THYROID-STIMULATING HORMONE TSH"
"ABNORMALITY OF THE OVARY","10","0.733376814028059","0.107152299883086","17.54","ctnnb1, eif2b2, fgf8a, mmp2, polr3h, ptena, sdhc, sec23b, stk11, tgfbr2","REDUCED PROSTAGLANDINS OVARY"
"GO:0048870","40","0.736728779738853","0.0186344118340781","20","acvr1l, arpc5b, bambia, bmp2a, cd63, cdk1, cdk6, creb3l3l, csnk2b, ctnnb1, cyp1b1, drd2b, f11r.1, f3a, f3b, fbxo5, fgf8a, fgfr4, foxo3b, gpia, gsk3ab, hif1ab, hspa5, igf1ra, ikbkap, mapk3, onecut1, P2RY1, pfn2l, pgam1a, prkcz, ptena, raf1b, rras, sgk1, sod2, syk, tbx1, tgfbr2, vcam1","INCREASED MOTILITY"
"GO:0009058","4","0.754336242900488","0.186938582459701","57.14","alas1, gcat, gmppb, got1","INCREASED TRIGLYCERIDE FORMATION; INCREASED TRIGLYCERIDE FORMATION; DECREASE TETRAHYDROBIOPTERIN; ROS FORMATION"
"GO:0046903","53","0.76389136125279","0.0175524232817437","22.94","acvr2b, adora2aa, agla, arpc5b, atp6ap1b, cacna1ba, calm1b, canx, cat, cd63, CD68, cfd, chrm2a, chrna6, csnk2b, ctsc, cyfip1, drd2b, gpia, hif1ab, hnf1ba, hsp90aa1.2, htr2cl1, impdh2, inhbab, lin7a, lpl, mapk3, neurog1, nfkb1, nme2b.2, nppa, nras, P2RY1, pa2g4b, pdia4, pdx1, pfn2l, pgam1a, pgam1b, pkma, prkcz, psmd9, ptgesl, ptprb, rab5ab, raf1b, SERP1, sgk1, sirt3, slc32a1, syk, tfap2b","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"GO:0003824","27","0.778857765946437","0.0254730975222881","41.54","acat1, agla, alas1, ckbb, ddc, echs1, exosc10, gcat, got1, hmgcl, hmgcs1, impdh2, lias, mdh1aa, mtap, naga, nfs1, ogg1, pfkpa, pgam1a, pgam1b, pgam2, pkma, ppm1bb, psat1, sucla2, tkta","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"GO:1903008","4","0.779285955826558","0.190252779073083","30.77","cdk1, gsk3ab, hif1ab, vdac1","DISRUPTION LYSOSOME"
"GO:0019904","27","0.780458733145935","0.0365248478331829","21.95","ar, arhgap1, calm1b, casp2, casp9, ccna2, csnk2b, ctnnb1, ddc, esrrga, f11r.1, fzd2, hdac1, hif1ab, hnrnpm, hsp90aa1.2, hspa5, lin7a, ptena, srsf10b, stk11, syk, tfdp1a, thraa, tra2b, ywhaqa, ywhaqb","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"ABNORMAL NASAL MORPHOLOGY","36","0.792107589697124","0.0181717045940297","23.23","agla, ahr1b, atp6v1e1b, bmp2a, cars, cpt2, ctnnb1, dhcr7, dhdds, eftud2, fgf8a, fzd2, gata5, hnrpkl, idh3a, igf1ra, lss, mdh1aa, mmp2, naga, nras, otx2, ppp2r1b, psat1, ptena, raf1b, rho, rpl18, rpl35a, rps15a, scn1lab, strada, tbx1, tfap2b, uba1, znf711","INCREASE SITE OF CONTACT NASAL TUMORS"
"MATING BEHAVIOR","3","0.797234910279009","0.282051525955487","33.33","hdac1, ptena, thraa","REDUCED ABILITY TO ATTRACT SPAWNING MATES"
"REPRODUCTIVE BEHAVIOR","3","0.797234910279009","0.282051525955487","30","hdac1, ptena, thraa","REDUCED SPAWNING BEHAVIOR"
"ABNORMALITY OF THE BLADDER","8","0.797577153265845","0.0682181789721138","15.38","cdc45, cdk6, gabra1, hnrpkl, scn1lab, stk11, tbx1, znf711","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"GO:0045444","4","0.800781718950691","0.187383549630491","9.76","bmp2a, htr2cl1, lpl, tfap2b","INCREASED ADIPOGENESIS"
"GO:0005488","238","0.804352347828522","0.0034331459733845","22.12","acat1, acvr1l, acvr2b, ahr1b, AK6, alas1, ar, arntl2, arpc1b, arpc4, arpc5b, atp5g1, atp5g3b, aurka, bambia, bmp2a, bmp2b, calb2b, canx, cars, cat, cdc42l, cdc45, cdh10a, cdk1, cdk6, cherp, ciapin1, cisd1, ckbb, cpsf2, creb3l3l, csnk1e, csnk1g2a, csnk2b, ctgfb, ctnnb1, cwc15, cyb5b, cyfip1, cyp1b1, cyp26a1, cyp26c1, cyp2ad3, cyp2p9, ddc, ddx39b, dhcr7, dnajb11, e2f8, eftud2, egr1, eif2b2, eif3g, eif3i, eif3s10, eif4a1b, eif4bb, eif4g2b, eif5, eno3, enoph1, ercc3, esrrga, exosc10, f11r.1, fabp10a, fasn, fbxo5, fdx1, fgf8a, fgfr4, foxo3b, fsta, fzd2, fzd7a, gata5, gcat, gk5, gli1, glrba, gmppb, gnat2, got1, gpia, grhl2b, gsk3ab, h2afx, hat1, hbbe3, hdac1, hif1aa, hif1ab, hmx2, hnf1ba, hnrnpm, hnrpkl, hoxb2a, hoxb5a, hoxb8a, hsf1, hsp90aa1.2, hspa5, idh3a, igf1ra, igfbp1a, igfbp5a, igfbp7, ikbkap, impdh2, inhbab, jak2a, lias, lig1, lin7a, lpl, lsm7, mapk3, mapk9, mapkapk2b, meis2b, mitfa, mmp11b, mmp14a, mmp2, mylpfa, ncor1, ndufab1a, neurog1, nfkb1, nfkb2, nfs1, nme2b.2, nol6, nos1, nppa, nr2f5, nr3c2, nr4a2b, nras, nvl, ogdhb, ogg1, onecut1, opn5, otx2, pa2g4b, pak2a, paqr7b, pax5, pcna, pdx1, pes, pfkpa, pfn2l, pgd, pitx3, pkma, plk1, polr3h, pparaa, ppm1bb, ppp1caa, prkaa1, prkcz, psat1, psmc1a, ptgesl, ptgs2a, ptpn4a, ptprb, rab11ba, rab5ab, raf1b, ran, rassf1, rbm28, rfc3, rho, rhoaa, rpl13a, rpl18, rpl19, rpl22, rpl7, rplp0, rps26, rps3, rps4x, rps5, rras, rrp7a, rxrba, sdhc, sec23b, sephs1, sf3a3, sf3b6, sfrp1b, sgk1, sirt3, snrpd1, sod2, sox9b, srpr, srsf10b, srsf1a, srsf6a, ssbp1, stk11, stk25a, strada, sucla2, sumo2b, syk, ta, tars, tbx1, tcf7, tcf7l1b, tfap2b, tfap2d, tfdp1a, tgfbr2, thop1, thraa, thrab, tkta, tnnc2, tnnt2a, tomm34, tra2b, ttk, uba1, ube2d1a, ube2kb, ubr5, znf711","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"INCREASED SUSCEPTIBILITY TO FRACTURES","8","0.81549536604025","0.0878042057164867","22.86","ctnnb1, fgf8a, ikbkap, mmp2, mtap, nras, ptena, scn1lab","INCREASED DISEASE SUSCEPTIBILITY"
"GO:0050673","17","0.826239061842743","0.0506871184359278","20.73","ar, bmp2a, cdk6, ctnnb1, f3a, f3b, fsta, gli1, hif1ab, hnf1ba, nme2b.2, nras, ptena, stk11, tbx1, ywhaqa, ywhaqb","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"UPPER MOTOR NEURON DYSFUNCTION","39","0.827044793729849","0.0177435259107626","8.23","acat1, atp6v1e1b, bckdha, cacna1ba, cars, ccnf, csnk2b, ctnnb1, cyp26c1, ddc, dhcr7, dhdds, echs1, eif2b2, ercc3, fdxr, fgf8a, gabbr2, gabra5, gmppb, gria2b, hmgcl, lias, mccc2, mdh1aa, naga, ndufb8, ndufs4, ogdhb, otx2, pitx3, psat1, ptena, rbm28, scn1lab, sucla2, tars, tgfbr2, znf711","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"GO:0004872","43","0.830997434846658","0.0259764319818909","17.99","acvr1l, acvr2b, adora2aa, ar, bmp2a, bmp2b, chrm2a, chrna6, drd2b, drd4a, esrrga, f3a, f3b, fgf8a, fgfr4, fzd2, fzd7a, gabbr2, gabra1, gabra5, glrba, gria2b, grik1b, htr2cl1, htr3a, igf1ra, inhbab, nppa, nr2f5, nr3c2, nr4a2b, opn1mw2, opn1sw1, opn5, P2RY1, paqr7b, pparaa, rho, rxrba, tgfbr2, thraa, thrab, valopa","ACTIVATION PXR/SXR"
"ABNORMAL OVARIAN MORPHOLOGY","7","0.834951667890585","0.16360222302399","18.92","fgf8a, mmp2, polr3h, ptena, sdhc, sec23b, stk11","PROMOTION OVARIAN GRANULAR CELL TUMORS; DECREASED OVARIAN E2; PROMOTION OVARIAN ADENOMAS"
"GO:0044414","7","0.842568753851387","0.0895794132833723","17.5","atp6ap1b, atp6v1c1a, atp6v1e1b, atp6v1f, canx, nos1, rab5ab","SUPPRESSION IMMUNE SYSTEM"
"GO:0006629","50","0.848761913335642","0.0203919504615634","24.27","acat1, alas1, aldh1a3, alg6, bdh2, bmp2a, cat, cpt2, csnk1g2a, csnk2b, cyp1b1, cyp26a1, cyp26c1, dhcr7, dhdds, dhrs3a, echs1, egr1, fasn, fdx1, fdxr, fgfr4, gk5, hacd3, hmgcl, hmgcs1, htr2cl1, igfbp7, lias, lpcat3, lpgat1, lpl, lss, mapk3, naga, ncor1, nfkb1, opn1sw1, pgp, ppp2r1b, prkaa1, prp19, ptena, ptgesl, rab5ab, ran, rdh10a, rho, sirt3, thraa","ALTERATION LIPID METABOLISM"
"GO:0043542","5","0.850446549876572","0.12814200308301","14.29","csnk2b, cyp1b1, gpia, hif1ab, ptena","INCREASED MIGRATION ENDOTHELIAL CELLS"
"ABNORMALITY OF THE ENDOMETRIUM","3","0.853938815497775","0.312392912983951","27.27","ptena, sdhc, sec23b","INCREASED HYPERPLASIA GLANDULAR EPITHELIAL CELLS OF ENDOMETRIUM; INCREASE HYPERPLASIA GLANDULAR EPITHELIAL CELLS OF ENDOMETRIUM; INCREASED ADENOSQUAMOUS CARCINOMAS OF ENDOMETRIUM"
"GO:0003707","6","0.858472659732236","0.131587757652756","18.75","ar, esrrga, nr3c2, paqr7b, rxrba, thraa","REDUCED MATURATION INDUCING STEROID RECEPTOR SIGNALLING OOCYTE"
"REGULATION OF PROTEOLYSIS","25","0.870734986008963","0.0325822293759359","22.32","adora2aa, aurka, bbc3, casp2, casp9, csnk1e, ctsc, f3a, fgfr4, gsk3ab, hdac1, hsf1, lpcat3, mapk9, pak2a, plk1, ptena, raf1b, rps3, sumo2b, syk, ube2kb, usp14, ywhaqa, ywhaqb","IMPAIRED PROTEOSTASIS"
"LIPID ACCUMULATION IN HEPATOCYTES","5","0.870841482660065","0.083178561452747","15.62","atp6ap1b, cpt2, hmgcl, hnf1ba, tars","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES"
"GO:0040011","44","0.880866792733055","0.0173645059381258","19.38","acvr1l, adora2aa, arpc5b, bambia, bmp2a, cd63, cdk1, cdk6, creb3l3l, csnk2b, ctnnb1, cyfip1, cyp1b1, drd2b, f11r.1, f3a, f3b, fbxo5, fgf8a, fgfr4, foxo3b, gpia, gsk3ab, hif1ab, hspa5, igf1ra, ikbkap, mapk3, onecut1, otx2, P2RY1, pfn2l, pgam1a, prkcz, ptena, raf1b, rras, sgk1, sod2, syk, tbx1, tgfbr2, usp14, vcam1","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0016055","9","0.908837007038355","0.0720397485753842","39.13","csnk2b, ctnnb1, fzd2, fzd7a, hdac1, sfrp1b, ta, tcf7, tcf7l1b","ALTERATION WNT PATHWAY"
"GO:0006839","12","0.915340068190256","0.0453034729657438","26.09","atp5c1, atp5g1, atp5g3b, cpt2, gsk3ab, hsp90aa1.2, prkaa1, si-ch211-194i10.5, tfdp1a, tomm34, ywhaqa, ywhaqb","REDUCTION CHOLESTEROL TRANSPORT IN MITOCHONDRIA"
"CTOME RHO GTPASES ACTIVATE NADPH OXIDASES","2","0.918104918575838","0.479508244016647","33.33","mapk3, prkcz","ACTIVATION NADPH OXIDASE"
"GO:0022851","2","0.920607914094253","0.390163811379707","66.67","gabra1, gabra5","REDUCTION IONOTROPIC GABA RECEPTOR CHLORIDE CHANNEL CONDUCTANCE; ACTIVATION IONOTROPIC GABA RECEPTOR CHLORIDE CHANNEL"
"GO:0048469","6","0.925287191752365","0.138448565300292","25","aurka, ccnb1, ctnnb1, fbxo5, hif1ab, ppp2r1b","INCREASED OOCYTE MATURATION"
"GO:0001775","45","0.931164176832847","0.0157802627424601","22.96","adora2aa, agla, ahr1b, arpc5b, casp3b, cat, cd63, CD68, cdk6, cfd, csnk2b, ctnnb1, ctsc, cyfip1, egr1, f11r.1, gpia, hsp90aa1.2, impdh2, inhbab, mapk3, nfkb1, nfkb2, nme2b.2, nppa, nras, onecut1, P2RY1, pa2g4b, pak2a, parp3, pgam1a, pgam1b, pkma, prkcz, ptgesl, ptprb, raf1b, rpl22, rps3, stk11, syk, tcf7, tgfbr2, vcam1","ACTIVATION DENDRITIC CELLS"
"TRIGLYCERIDE METABOLIC PROCESS","4","0.941756529486215","0.163906835431842","25","cat, gk5, lpgat1, lpl","ACCUMULATION TRIGLYCERIDE"
"NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA","5","0.952790425773046","0.136302159850356","10.42","csnk1e, csnk2b, ctnnb1, fzd2, tcf7","INCREASE HERITABLE MUTATIONS IN OFFSPRING"
"LOCOMOTORY BEHAVIOR","8","0.972037363441151","0.102519291737826","12.9","adora2aa, aldh1a3, egr1, hoxb8a, htr2cl1, ncor1, pitx3, ptena","REDUCED SWIMMING SPEED; REDUCED SWIMMING PERFORMANCE"
"GO:0000003","46","0.985400472099824","0.0200923234770592","22.66","acvr1l, ar, aurka, casp2, casp3b, ccnb1, ccnf, cdk1, ctnnb1, e2f8, egr1, eif2b2, fbxo5, fgf8a, fsta, gli1, grhl2b, h2afx, hif1ab, hmgcs1, hsf1, hspa5, igfbp7, inhbab, mapk3, mmp2, ncoa4, neurog1, nppa, P2RY1, paqr7b, pax5, pcna, pgam1a, pgam2, plk1, ppp2r1b, ptena, rdh10a, stk11, tcf7, tgfbr2, thraa, ttk, txn, zgc-56493","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0044703","29","0.995384711532624","0.0364712799715692","25","acvr1l, ar, aurka, ccnb1, cdk1, ctnnb1, fbxo5, fsta, gli1, h2afx, hsf1, igfbp7, inhbab, mapk3, mmp2, nppa, P2RY1, paqr7b, pax5, pgam2, plk1, ppp2r1b, ptena, stk11, tgfbr2, thraa, ttk, txn, zgc-56493","N/A REPRODUCTIVE FAILURE"
"GO:0099536","26","0.999098097731215","0.0440555437187567","23.42","adora2aa, cacna1ba, chrm2a, chrna6, ctnnb1, cyfip1, drd2b, gabbr2, gabra1, gabra5, gria2b, grik1b, gsk3ab, htr2cl1, htr3a, lin7a, nos1, P2RY1, pfn2l, prkcz, ptena, rab5ab, rpl22, slc32a1, usp14, vdac1","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"GO:0046562","7","1.00085831857289","0.100250476603991","25.93","eno3, gpia, pfkpa, pgam1a, pgam1b, pgam2, pkma","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY"
"NADPH REGENERATION","4","1.00414992327833","0.169558612811094","80","pgam1a, pgam1b, pgd, tkta","INHIBITION HMG-COA REDUCTASE"
"ABNORMAL NEURON MORPHOLOGY","3","1.02906469071403","0.243438779225355","18.75","ccnf, rbm28, uba1","HYPERPOLARISATION NEURON"
"GO:0015631","4","1.03694015410574","0.159862705461857","21.05","gli1, ogg1, plk1, rps3","BINDING TUBULIN"
"MALE REPRODUCTIVE SYSTEM NEOPLASM","3","1.03778308017591","0.279940348045444","20","ar, ptena, stk11","MALFORMATION MALE REPRODUCTIVE TRACT; INDUCTION MALE REPRODUCTIVE TRACT; MALFORMED MALE REPRODUCTIVE TRACT"
"GO:0007009","3","1.04158955824512","0.280856244735257","33.33","ar, ptena, SERP1","NARCOSIS"
"PANCREATIC HYPOPLASIA","2","1.04826714228196","0.40569679858657","28.57","hnf1ba, pdx1","INCREASED PANCREATIC ACINAR TUMORS"
"GO:0016310","33","1.06063222565862","0.0275970263461916","26.4","acvr1l, acvr2b, AK6, aurka, cdk1, cdk6, ckbb, csnk1e, csnk1g2a, csnk2b, fgfr4, gk5, gsk3ab, igf1ra, jak2a, mapk3, mapk9, mapkapk2b, nme2b.2, pak2a, pfkpa, pkma, plk1, prkaa1, prkcz, raf1b, sephs1, sgk1, stk11, strada, syk, tgfbr2, ttk","ACTIVATION SP1"
"ABNORMAL BLOOD SODIUM CONCENTRATION","4","1.0614546363546","0.168680075419817","44.44","cpox, ikbkap, nfkb2, nr3c2","DECREASED SODIUM CONDUCTANCE 2; DECREASED SODIUM REABSORPTION"
"NUCLEAR RECEPTORS","3","1.06147271343514","0.244729821130727","5.77","ar, rxrba, thraa","ACTIVATION HEPATIC NUCLEAR RECEPTORS"
"REGULATION OF SODIUM ION TRANSPORT","2","1.08832539388468","0.425193681168532","16.67","ahcyl1, nos1","INHIBITION SODIUM CHANNEL; MODULATION SODIUM CHANNEL"
"APOPTOSIS","6","1.08884187182053","0.0862227374668821","10.71","bbc3, casp2, casp3b, casp9, igf1ra, nfkb1","INCREASED APOPTOSIS ADENOMAS/CARCINOMAS FOLLICULAR CELL"
"TUBE FEEDING","5","1.09388434963646","0.110644786142691","29.41","csnk2b, fgf8a, hnrpkl, ppp2r1b, psat1","INHIBITION FEEDING"
"G VEGF SIGNALING PATHWAY","5","1.10215280747835","0.158454645488999","23.81","casp9, mapk3, nos1, nras, raf1b","REDUCED PRODUCTION VEGF"
"GO:0006281","14","1.16214616733667","0.0489398897631249","16.47","cdc45, cdk1, csnk1e, ercc3, h2afx, hsf1, lig1, ogg1, parp3, pcna, prp19, rfc3, rps3, ubr5","N/A INSUFFICIENT OR INCORRECT DNA REPAIR; INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS; OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS; INCREASED DNA DAMAGE-REPAIR"
"GO:0008283","3","1.19574657337597","0.259627704635039","33.33","hoxb8a, pes, tacc3","PROLIFERATION CELL PROLIFERATION IN THE ABSENCE OF CYTOTOXICITY; ACTIVATION/PROLIFERATION T-CELLS; ALTERATIONS CELLULAR PROLIFERATION / HYPERPLASIA; INCREASE PROLIFERATION LEYDIG CELL; INCREASE MITOGENIC CELL PROLIFERATION HEPATOCYTES; INCREASE HYPERTROPHY AND PROLIFERATION FOLLICULAR CELL; INCREASE REGENERATIVE CELL PROLIFERATION CORNEAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION FORESTOMACH EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION HEPATOCYTES; INCREASE REGENERATIVE CELL PROLIFERATION UROTHELIAL CELLS; INCREASE CELL PROLIFERATION; INCREASE PROLIFERATION OF GOBLET CELLS; INCREASED HYPERTROPHY AND PROLIFERATION FOLLICULAR CELL; PROLIFERATION/CLONAL EXPANSION SMOOTH MUSCLE; INCREASED CELLULAR PROLIFERATION / HYPERPLASIA OF ACINAR CELLS; PROLIFERATION/CLONAL EXPANSION ABERRANT BASAL CELLS; INCREASED CELL PROLIFERATION MESOTHELIUM; INCREASE CELL PROLIFERATION EPITHELIAL CELLS"
"ABNORMAL FORM OF THE VERTEBRAL BODIES","5","1.20391625158638","0.164974758566395","15.15","acvr1l, dhcr7, fzd2, mmp2, ptena","CLONAL EXPANSION/CELL PROLIFERATION TO FORM ALTERED HEPATIC FOCI AHF"
"OXIDATIVE STRESS","3","1.22709112679023","0.264428799840094","12.5","cat, nfkb1, sod2","PROPAGATION OXIDATIVE STRESS; N/A OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASED OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASE ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS; INCREASED ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS"
"GO:0006809","2","1.22911024964148","0.387835760817212","66.67","nos1, tnnt2a","DEPLETION NITRIC OXIDE"
"ABNORMAL CORNEAL EPITHELIUM MORPHOLOGY","4","1.2461943290037","0.160026366606559","30.77","ercc3, ikbkap, scn1lab, tars","INCREASED ACCUMULATION OF ALPHA2U MICROGLOBULIN PROXIMAL TUBULAR EPITHELIUM"
"PSYCHOGENIC NON EPILEPTIC SEIZURE","2","1.2705514321534","0.629776834860331","15.38","gabbr2, sdhc","OCCURRENCE EPILEPTIC SEIZURE"
"CTOME FOXO MEDIATED TRANSCRIPTION","10","1.27267744950052","0.0789537728236765","35.71","bbc3, cat, foxo3b, hdac1, sirt3, sod2, stk11, txn, ywhaqa, ywhaqb","ACTIVATION FOXO"
"GO:0042060","18","1.28360559051115","0.0415835245162152","20.45","adora2aa, casp3b, ccnb1, eno3, f11r.1, f3a, f3b, gata5, hdac1, hif1ab, mapk3, P2RY1, pkma, ptena, rab5ab, raf1b, syk, tgfbr2","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"GO:0045333","14","1.28787050778872","0.058080670193798","19.44","C24H11orf65, cat, ccnb1, cdk1, cisd1, hif1ab, idh3a, mdh1aa, ndufb2, ndufb8, ndufs4, sdhc, sirt3, sucla2","INCREASE OXIDATIVE METABOLISM"
"GO:0006915","8","1.29402174400907","0.0709790537574387","25.81","casp2, casp3b, casp9, ciapin1, dap3, ercc3, sgk1, tgfbr2","CHANGES/INHIBITION CELLULAR HOMEOSTASIS AND APOPTOSIS; DECREASED APOPTOSIS EPITHELIAL CELLS; INCREASED APOPTOSIS DECREASED LEYDIG CELLS"
"ABNORMAL CARDIAC TEST","2","1.30282594408377","0.510905667651762","15.38","gmppb, nppa","INCREASED CARDIAC ARRTHYMIA"
"GO:0009611","23","1.3233375178432","0.0320340469315961","20.54","adora2aa, aurka, casp3b, ccnb1, cdk1, drd2b, eno3, f11r.1, f3a, f3b, gata5, gli1, hdac1, hif1ab, mapk3, P2RY1, pdx1, pkma, ptena, rab5ab, raf1b, syk, tgfbr2","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0006898","7","1.33205832837778","0.0947282832618076","18.42","canx, cd63, drd2b, hsp90aa1.2, rab5ab, syk, tgfbr2","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT; INCREASED LDL UPTAKE"
"GO:0051899","6","1.33631100215364","0.136210611021891","28.57","adora2aa, cacna1ba, chrna6, got1, prkcz, scn1lab","OCCURRENCE A PAROXYSMAL DEPOLARIZING SHIFT; PROLONGED DEPOLARIZATION OF NEURONAL MEMBRANE"
"REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY","3","1.33895486834178","0.223878519877047","37.5","hif1ab, hsp90aa1.2, nos1","INHIBITION INDUCIBLE NITRIC OXIDE SYNTHASE BY METABOLITE CGA 265307"
"CHOLESTASIS","8","1.35204213171183","0.0721528317134837","22.86","atp6ap1b, cpox, dhcr7, gpia, hmgcl, hnf1ba, lpl, sec23b","INCREASED CHOLESTASIS; CHOLESTASIS PATHOLOGY"
"DISRUPTION OF POSTSYNAPTIC SIGNALLING BY CNV","2","1.36276155465017","0.600796544134053","20","cyfip1, mapk3","REDUCTION EXCITATORY POSTSYNAPTIC POTENTIAL; GENERATION AMPLIFIED EXCITATORY POSTSYNAPTIC POTENTIAL EPSP"
"RESPONSE TO REACTIVE OXYGEN SPECIES","17","1.36370309845708","0.0414529034575551","30.36","casp3b, cat, ccna2, cyp1b1, hdac1, hif1ab, hsf1, mapk3, mapk9, mmp2, nos1, pcna, prkaa1, rps3, sod2, tra2b, txn","INCREASED REACTIVE OXYGEN SPECIES"
"GO:0019932","16","1.3756107875939","0.0512059884511298","26.23","adora2aa, ahr1b, calm1b, cherp, drd2b, gsk3ab, htr2cl1, ndufs4, nme2b.2, nos1, nppa, pdx1, ppp2r1b, prkaa1, syk, vcam1","INCREASED SECOND MESSENGER PRODUCTION"
"NEOPLASM OF THE SKIN","9","1.3810958372361","0.0944816312527478","27.27","ctnnb1, ctsc, ercc3, nras, ptena, sdhc, sec23b, tars, tgfbr2","SENSITISATION SKIN"
"SMOOTH MUSCLE CELL PROLIFERATION","7","1.39216797703117","0.116392020375269","26.92","ctnnb1, ddx39b, igfbp5a, mmp2, ptena, sod2, tgfbr2","HYPERTROPHY/HYPERPLASIA SMOOTH MUSCLE"
"GO:0006412","19","1.41506598465039","0.0443396572141841","17.59","eif2b2, eif3g, eif3i, eif3s10, eif4a1b, eif4bb, eif5, rpl13a, rpl18, rpl19, rpl22, rpl35a, rpl36, rpl38, rps15a, rps26, rps3, rps4x, rps5","ALTERED PROTEIN PRODUCTION"
"BRADYCARDIA","2","1.41794355448745","0.484903552142851","33.33","nppa, scn1lab","INCREASED ATRIOVENTRICULAR BLOCK AND BRADYCARDIA"
"SYNAPTIC TRANSMISSION GLUTAMATERGIC","3","1.45274642544157","0.229382455771504","23.08","adora2aa, gria2b, grik1b","REDUCED PRESYNAPTIC RELEASE OF GLUTAMATE"
"GO:0072358","23","1.45442042849449","0.0328006133621884","20.72","acvr1l, acvr2b, ahr1b, ctnnb1, cyp1b1, dhcr7, e2f8, egr1, f3a, f3b, fgf8a, hif1ab, mmp2, pkma, ptena, ptprb, rras, sod2, stk11, syk, tbx1, tfap2b, tgfbr2","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"GO:0060291","4","1.47839595248706","0.184308665765186","28.57","adora2aa, drd2b, prkcz, ptena","DECREASED LONG-TERM POTENTIATION LTP"
"GLYCOLYSIS AND GLUCONEOGENESIS","8","1.5016349650255","0.0856097907378358","34.78","eno3, got1, gpia, mdh1aa, pgam1a, pgam1b, pgam2, pkma","DECREASED PCK1 EXPRESSION CONTROL POINT FOR GLYCOLYSIS/GLUCONEOGENESIS PATHWAY"
"GO:0022414","8","1.52668526507904","0.108811327356486","22.22","ar, aurka, ccnb1, fbxo5, fsta, h2afx, paqr7b, ttk","INCREASED REPRODUCTIVE SUCCESS"
"ELECTRON TRANSPORT CHAIN","11","1.5382642605687","0.0705138495907736","16.18","C24H11orf65, ccnb1, cdk1, ciapin1, cyb5b, dhrs3a, fdx1, ndufb2, ndufb8, ndufs4, sdhc","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"GO:0006635","4","1.54173480519312","0.227017859047683","20","acat1, bdh2, cpt2, echs1","DECREASED PEROXISOMAL FATTY ACID BETA OXIDATION OF FATTY ACIDS; DECREASED MITOCHONDRIAL FATTY ACID BETA OXIDATION; DECREASED MITOCHONDRIAL FATTY ACID BETA-OXIDATION; INHIBITION MITOCHONDRIAL FATTY ACID BETA-OXIDATION"
"REGULATION OF POTASSIUM ION TRANSPORT","4","1.59228332626235","0.156771964449244","25","cd63, nos1, nppa, ptena","INHIBITION ETHER-A-GO-GO ERG VOLTAGE-GATED POTASSIUM CHANNEL"
"CYANOSIS","4","1.64301713197955","0.168149726790251","21.05","gabra1, ikbkap, psat1, scn1lab","N/A CYANOSIS OCCURS"
"GO:0001963","2","1.6765040470421","0.516137963422147","16.67","adora2aa, drd2b","INCREASE DOPAMINERGIC ACTIVITY; DECREASED DOPAMINERGIC ACTIVITY"
"GO:0007588","2","1.6765040470421","0.516137963422147","14.29","adora2aa, drd2b","INCREASE BILIARY EXCRETION TH GLUCURONIDE"
"GO:0019098","2","1.67653839097403","0.449068689798422","22.22","ptena, thraa","ALTERED REPRODUCTIVE BEHAVIOUR; REDUCED BROOD CARE"
"ABNORMAL PROLACTIN LEVEL","2","1.69718281690744","0.53813193223104","25","otx2, rbm28","DECREASED PROLACTIN"
"RENAL TUBULAR DYSFUNCTION","4","1.73365863668519","0.171823863352532","15.38","hnf1ba, ndufb8, ndufs4, pdx1","INCREASE HYPERPLASIA RENAL TUBULAR CELLS; INCREASE CYTOTOXICITY RENAL TUBULAR CELL; INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR; OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS"
"GO:0048856","3","1.82858751641272","0.217045057615317","25","igf1ra, nr2f5, rxrba","ALTERED NEUROANATOMY"
"ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION","2","1.91572830591319","0.388659162697858","18.18","dhcr7, lpl","DECREASED CHOLESTEROL; PERTURBATION OF CHOLESTEROL"
"GO:0048813","2","1.93407843273702","0.492952146260684","15.38","ptena, stk11","ABERRANT DENDRITIC MORPHOLOGY"
"GO:0016209","4","1.9392685710844","0.208413689674617","36.36","cat, gstk1, sod2, zgc-56493","OXIDATION GLUTATHIONE"
"GO:0007051","11","1.94098570366504","0.0748592028525701","40.74","aurka, ccnb1, fbxo5, ncor1, parp3, plk1, ppp2r1b, ran, rps3, tacc3, ttk","DISORGANIZATION SPINDLE"
"BLADDER CANCER","4","1.95769352496643","0.21459941535905","9.52","mmp2, nras, raf1b, rassf1","INCREASE CANCER"
"SOMATIC MUTATION","7","2.00984079653861","0.124772710555296","8.33","ar, aurka, ctnnb1, nras, ptena, stk11, tgfbr2","INCREASED INDUCED MUTATIONS IN CRITICAL GENES; INCREASE MUTATIONS; INCREASE MUTATIONS IN CRITICAL GENES"
"MORTALITY AGING","4","2.120267460446","0.198872108979421","15.38","hmgcl, nras, ogdhb, tgfbr2","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"CYTOPLASMIC RIBOSOMAL PROTEINS","14","2.14170147432902","0.0579331952237559","9.72","rpl13a, rpl18, rpl19, rpl22, rpl35a, rpl36, rpl38, rpl7, rplp0, rplp2l, rps15a, rps3, rps4x, rps5","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE"
"RESPONSE TO NITRIC OXIDE","2","2.15095540219571","0.387719317269632","28.57","ccna2, txn","DECREASED NITRIC OXIDE"
"GO:0001935","5","2.15896264484995","0.181140118271231","13.89","bmp2a, f3a, f3b, hif1ab, nras","INCREASED PROLIFERATION ENDOTHELIAL CELLS"
"GO:0007059","9","2.16144072678841","0.0876185015587704","20.45","ccnb1, ctnnb1, fbxo5, plk1, ppp2r1b, ran, rps3, tacc3, ttk","INCREASED CHROMOSOME MISSEGGREGATION"
"SQUAMOUS CELL CARCINOMA","4","2.22029958992011","0.198181811065873","40","ctsc, ercc3, tars, tgfbr2","INCREASE PAPILLOMAS/CARCINOMAS SQUAMOUS CELLS; INCREASE RESPIRATORY OR SQUAMOUS METAPLASIA; SQUAMOUS METAPLASIA ABERRANT BASAL CELLS"
"NEURON CELLULAR HOMEOSTASIS","2","2.22162861420504","0.457150388490988","33.33","P2RY1, prkaa1","ALTERED NEUROPHYSIOLOGY"
"CTOME VEGFR2 MEDIATED CELL PROLIFERATION","3","2.27687504813247","0.272609134400982","50","ahcyl1, nras, prkcz","INHIBITION VEGFR2"
"ELEVATED RED CELL ADENOSINE DEAMINASE LEVEL","3","2.29051037831612","0.360263322572401","16.67","rpl18, rpl35a, rps15a","INCREASED CYCLIC ADENOSINE MONOPHOSPHATE"
"PURE RED CELL APLASIA","3","2.29051037831612","0.360263322572401","15","rpl18, rpl35a, rps15a","N/A METHEMOGLOBINEMIA DECREASED HEMOGLOBIN HEMATOCRIT RED BLOOD CELL NUMBER"
"CTOME ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA","2","2.29411965078076","0.447711084047714","18.18","ywhaqa, ywhaqb","DIRECT MITOCHONDRIAL INHIBITION; MITOCHONDRIAL IMPAIRMENT"
"G OOCYTE MEIOSIS","13","2.32876065606002","0.054911764919765","32.5","anapc10, ar, aurka, calm1b, ccnb1, cdk1, fbxo5, igf1ra, mapk3, plk1, ppp2r1b, ywhaqa, ywhaqb","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE"
"NRF2 PATHWAY","5","2.43629572735404","0.112204630062858","12.5","egr1, hsp90aa1.2, pgd, tgfbr2, txn","ACTIVATION NRF2"
"GO:0042701","11","2.46567671813702","0.0665377717192848","32.35","anapc10, aurka, ccna2, ccnb1, cdk1, hsp90aa1.2, igf1ra, mapk3, mapk9, plk1, raf1b","DECREASED PROGESTERONE FROM CORPUS LUTEUM"
"ARYL HYDROCARBON RECEPTOR PATHWAY","3","2.55331861356176","0.189736005548871","6.25","ahr1b, cyp1b1, hsp90aa1.2","UP REGULATION CYP1A1; ACTIVATION AHR"
"GO:0030154","11","2.70566719209983","0.0678915866326534","16.92","cyfip1, fsta, neurog1, nr2f5, onecut1, paqr7b, pparaa, rxrba, tgfbr2, thraa, thrab","DIFFERENTIATION OF MYOFIBROBLAST"
"DNA DAMAGE RESPONSE","9","2.94646933061134","0.0706174942956573","15.52","bbc3, casp3b, casp9, ccnb1, cdk1, cdk6, h2afx, ywhaqa, ywhaqb","INCREASED DNA DAMAGE-REPAIR"
"SYNTHESIS AND DEGRADATION OF KETONE BODIES","3","4.14000606273787","0.210736236606191","50","acat1, hmgcl, hmgcs1","NOT INCREASED CIRCULATING KETONE BODIES"
"GO:0008137","3","4.31602517498413","0.205091183398168","33.33","C24H11orf65, ndufb8, ndufs4","INHIBITION NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I"
"GO:1903409","3","4.66071641479649","0.102886842613625","12","cyp1b1, hsp90aa1.2, nos1","INCREASE ROS PRODUCTION; PRODUCTION REACTIVE OXYGEN SPECIES"
"CTOME SYNTHESIS OF KETONE BODIES","4","4.99432257636254","0.1353263809514","50","acat1, bdh2, hmgcl, hmgcs1","DECREASED KETOGENESIS PRODUCTION OF KETONE BODIES; DECREASED KETOGENESIS"
"GO:0006120","4","5.03915217325734","0.130018570437403","14.81","C24H11orf65, ndufb2, ndufb8, ndufs4","BINDING OF INHIBITOR NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I"
"ABNORMAL SOCIAL BEHAVIOR","5","5.07292768758826","0.0847168366752718","19.23","ercc3, gabbr2, gabra1, ndufs4, tars","ABNORMAL FORAGING ACTIVITY AND BEHAVIOR"
"SEROTONIN AND ANXIETY","2","5.716941899334","0.170634851298619","16.67","gabra1, htr2cl1","DECREASED ANXIETY"
"GO:0042311","3","7.2173364535079","0.0637719220310034","20","adora2aa, nos1, sod2","IMPAIRED VASODILATION"
